QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
NASDAQ:AXDX

Accelerate Diagnostics Insider Trades

$3.75
-0.35 (-8.54%)
(As of 01/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.71
$4.04
50-Day Range
$3.75
$6.97
52-Week Range
$3.71
$15.60
Volume
460,651 shs
Average Volume
302,388 shs
Market Capitalization
$230.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.8

Accelerate Diagnostics (NASDAQ:AXDX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
45.30%

Number Of
Insiders Buying
(Last 12 Months)
2

Amount Of
Insider Buying
(Last 12 Months)
$7.54 M

Number Of
Insiders Selling
(Last 12 Months)
3

Amount Of
Insider Selling
(Last 12 Months)
$765.83 K

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get AXDX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Accelerate Diagnostics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Accelerate Diagnostics (NASDAQ AXDX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/13/2022Jack W SchulerDirectorBuy100,000$4.03$403,000.00  
1/10/2022Jack W SchulerDirectorBuy45,226$4.34$196,280.84  
1/4/2022Jack W SchulerDirectorBuy10,000$4.93$49,300.00  
12/28/2021Jack W SchulerDirectorBuy30,000$4.87$146,100.00  
12/20/2021Jack W SchulerDirectorBuy54,541$4.73$257,978.93  
12/16/2021Jack W SchulerDirectorBuy20,000$4.60$92,000.00  
11/29/2021Jack W SchulerDirectorBuy1,000,000$5.00$5,000,000.00  
11/18/2021Jack W SchulerDirectorBuy116,444$5.20$605,508.80  
9/27/2021Hany MassaranyDirectorBuy10,000$5.30$53,000.00  
9/23/2021Jack W SchulerDirectorBuy27,353$5.50$150,441.50  
6/22/2021Jack PhillipsCEOSell23,479$7.94$186,423.26136,177  
5/14/2021Jack W SchulerDirectorBuy29,577$9.20$272,108.40  
5/13/2021Jack PhillipsCEOSell25,064$6.76$169,432.6499,081  
5/13/2021Ron PriceInsiderSell6,282$6.76$42,466.3221,209  
5/13/2021Steven ReichlingCFOSell8,303$6.76$56,128.2842,975  
1/29/2021Jack W SchulerDirectorBuy30,868$10.18$314,236.24  
1/26/2021Steven ReichlingCFOSell24,910$12.50$311,375.0034,061  
11/9/2020Steven ReichlingCFOSell39,329$9.50$373,625.5052,629  
6/18/2020Romney HumphriesInsiderSell3,000$12.00$36,000.004,000  
6/16/2020Romney HumphriesInsiderSell4,000$11.00$44,000.004,000  
6/15/2020Jack W SchulerDirectorBuy95,492$9.86$941,551.12  
6/11/2020Jack W SchulerDirectorBuy129,000$9.18$1,184,220.00  
6/9/2020Jack W SchulerDirectorBuy180,955$9.63$1,742,596.65  
5/13/2020Jack W SchulerDirectorBuy89,055$9.46$842,460.30  
5/11/2020Jack W SchulerDirectorBuy20,000$9.99$199,800.00  
5/6/2020Jack W SchulerDirectorBuy10,868$10.50$114,114.00
5/4/2020Jack W SchulerDirectorBuy1,204$10.02$12,064.08  
4/24/2020Jack W SchulerDirectorBuy5,001$11.04$55,211.04  
4/22/2020Jack W SchulerDirectorBuy157,688$9.47$1,493,305.36  
4/20/2020Jack W SchulerDirectorBuy59,357$9.40$557,955.80  
3/30/2020Jack W SchulerDirectorBuy80,000$8.59$687,200.00  
3/27/2020Jack W SchulerDirectorBuy101,963$8.33$849,351.79  
3/25/2020Jack W SchulerDirectorBuy150,000$7.70$1,155,000.00  
3/23/2020Jack W SchulerDirectorBuy172,900$5.89$1,018,381.0044,670  
3/19/2020Steven ReichlingCFOBuy1,000$6.47$6,470.00
11/28/2018Thomas D BrownDirectorBuy10,000$13.65$136,500.0016,381  
11/27/2018Steven ReichlingInsiderBuy850$13.13$11,160.502,300  
11/8/2018John PatienceDirectorBuy10,000$14.96$149,600.0044,670  
11/8/2018Steven ReichlingInsiderBuy750$14.72$11,040.001,450  
5/14/2018Jack W SchulerDirectorBuy65,000$19.97$1,298,050.00  
5/11/2018Jack W SchulerDirectorBuy100,000$19.33$1,933,000.00  
3/5/2018Jack W SchulerDirectorBuy100$25.00$2,500.00  
3/1/2018Jack W SchulerDirectorBuy15,000$25.15$377,250.00  
2/22/2018Jack W SchulerDirectorBuy10,000$25.21$252,100.00  
2/20/2018Jack W SchulerDirectorBuy20,000$24.95$499,000.00  
11/17/2017Jack W SchulerDirectorBuy5,500$22.00$121,000.00  
11/15/2017Jack W SchulerDirectorBuy20,000$20.00$400,000.00  
11/13/2017Jack W SchulerDirectorBuy20,000$18.98$379,600.00  
11/10/2017Jack W SchulerDirectorBuy51,181$18.67$955,549.27  
11/8/2017Jack W SchulerDirectorBuy50,000$18.46$923,000.00  
11/6/2017Jack W SchulerDirectorBuy340,964$18.51$6,311,243.6444,670  
10/18/2017Jack W SchulerDirectorBuy45,000$20.14$906,300.00  
10/16/2017Jack W SchulerDirectorBuy59,922$20.07$1,202,634.54  
10/13/2017Jack W SchulerDirectorBuy61,300$19.29$1,182,477.00  
10/12/2017Jack W SchulerDirectorBuy276,200$19.74$5,452,188.00  
10/11/2017Jack W SchulerDirectorBuy51,600$20.27$1,045,932.00  
8/21/2017Jack W SchulerDirectorBuy50,000$21.45$1,072,500.00  
8/17/2017Lawrence MehrenInsiderSell223,215$22.40$5,000,016.00762,381  
8/15/2017Jack W SchulerDirectorBuy8,200$21.35$175,070.00  
8/14/2017Jack W SchulerDirectorBuy23,400$21.35$499,590.00  
8/11/2017Jack W SchulerDirectorBuy80,000$21.43$1,714,400.00  
6/21/2017Steven ReichlingInsiderSell30,000$28.90$867,000.0030,700  
1/9/2017Lawrence MehrenInsiderSell400,068$19.00$7,601,292.00  
1/9/2017Matthew StrobeckDirectorBuy8,000$19.00$152,000.002,045,560  
6/30/2016Jack W SchulerDirectorBuy90,147$13.95$1,257,550.65  
6/14/2016Jack W SchulerDirectorBuy14,033$13.67$191,831.11  
6/13/2016Jack W SchulerDirectorBuy15,967$13.70$218,747.90  
6/10/2016Jack W SchulerDirectorBuy88,316$14.69$1,297,362.04  
6/9/2016Jack W SchulerDirectorBuy101,272$14.14$1,431,986.08  
5/20/2016Jack W SchulerDirectorBuy4,270$11.04$47,140.80  
5/17/2016Jack W SchulerDirectorBuy10,000$11.45$114,500.00  
5/16/2016Jack W SchulerDirectorBuy11,511$11.91$137,096.01  
5/13/2016Jack W SchulerDirectorBuy20,000$12.45$249,000.00  
2/9/2016Jack W SchulerDirectorBuy600,000$11.86$7,116,000.00  
2/8/2016Jack W SchulerDirectorBuy20,000$12.32$246,400.00  
2/5/2016Jack W SchulerDirectorBuy7,308$12.65$92,446.20  
2/4/2016Jack W SchulerDirectorBuy10,000$12.98$129,800.00  
2/3/2016Jack W SchulerDirectorBuy50,100$13.09$655,809.00  
2/2/2016Jack W SchulerDirectorBuy20,000$13.46$269,200.00  
1/21/2016Jack W SchulerDirectorBuy10,000$15.02$150,200.00  
12/10/2015Larry N FeinbergMajor ShareholderBuy117,647$17.00$1,999,999.00173,079  
11/5/2015Jack W SchulerDirectorBuy11,899$16.81$200,022.19  
11/4/2015Jack W SchulerDirectorBuy52,837$16.81$888,189.97  
10/22/2015Jack W SchulerDirectorBuy2,160$15.82$34,171.20  
9/29/2015Brink Frank Jm TenDirectorBuy9,800$15.24$149,352.009,800  
8/26/2015Jack W SchulerDirectorBuy10,000$17.81$178,100.00  
8/25/2015Jack W SchulerDirectorBuy10,000$18.56$185,600.00  
4/17/2015Jack W SchulerDirectorBuy11,000$21.94$241,340.00  
3/19/2015Matthew StrobeckDirectorBuy2,000$22.04$44,080.00  
3/9/2015Jack W SchulerDirectorBuy22,584$17.18$387,993.12  
1/5/2015Jack W SchulerDirectorBuy18,000$18.93$340,740.00  
9/22/2014Jack W SchulerDirectorBuy2,588$16.44$42,546.72  
9/19/2014Jack W SchulerDirectorBuy32,411$16.67$540,291.37  
8/21/2014Jack W SchulerDirectorBuy2,900$16.79$48,691.00  
8/5/2014Larry N FeinbergMajor ShareholderBuy11,835$15.92$188,413.20  
8/5/2014Matthew StrobeckDirectorBuy20,000$16.70$334,000.00  
8/4/2014Matthew StrobeckDirectorBuy20,000$16.70$334,000.00  
7/16/2014Larry N FeinbergMajor ShareholderBuy20,000$21.54$430,800.00  
7/1/2014Jack W SchulerDirectorBuy8,698$25.70$223,538.60  
6/30/2014Jack W SchulerDirectorBuy10,000$26.09$260,900.00  
6/30/2014Larry N FeinbergMajor ShareholderBuy20,000$25.72$514,400.00  
5/12/2014Larry N FeinbergMajor ShareholderBuy297,618$16.80$4,999,982.40  
2/5/2014Larry N FeinbergMajor ShareholderBuy8,554$24.78$211,968.12  
1/27/2014Larry N FeinbergMajor ShareholderBuy16,307$13.09$213,458.63  
12/31/2013Larry N FeinbergMajor ShareholderBuy84,081$12.29$1,033,355.49  
10/30/2013Larry N FeinbergMajor ShareholderBuy10,000$12.95$129,500.00  
8/30/2013Larry N FeinbergMajor ShareholderBuy16,001$9.76$156,169.76  
8/28/2013Larry N FeinbergMajor ShareholderBuy158,445$9.80$1,552,761.00  
8/16/2013Jack W SchulerDirectorBuy78,494$7.88$618,532.72  
8/14/2013Jack W SchulerDirectorBuy413,090$8.04$3,321,243.60  
8/14/2013Larry N FeinbergMajor ShareholderBuy36,814$7.24$266,533.36  
8/9/2013Larry N FeinbergMajor ShareholderBuy35,168$7.30$256,726.40  
6/21/2013Larry N FeinbergMajor ShareholderBuy114,250$8.00$914,000.00  
6/12/2013Larry N FeinbergMajor ShareholderBuy7,175$8.41$60,341.75  
6/7/2013Larry N FeinbergMajor ShareholderBuy45,508$8.33$379,081.64  
(Data available from 1/1/2013 forward)












Accelerate Diagnostics (NASDAQ:AXDX) Insider Trade Frequently Asked Questions

Who is on Accelerate Diagnostics's Insider Roster?

The list of insiders at Accelerate Diagnostics includes Hany Massarany, Jack Phillips, Jack W Schuler, Romney Humphries, Ron Price, and Steven Reichling.Learn more on AXDX's insiders

What percentage of Accelerate Diagnostics stock is owned by insiders?

45.30% of Accelerate Diagnostics stock is owned by insiders. Learn more on AXDX's insider holdings

Which Accelerate Diagnostics insiders have been buying company stock?

The following insiders have purchased Accelerate Diagnostics stock in the last 24 months: Hany Massarany ($53,000.00), Jack W Schuler ($18,340,165.85), and Steven Reichling ($6,470.00).

How much insider buying is happening at Accelerate Diagnostics?

Insiders have purchased a total of 2,728,492 Accelerate Diagnostics shares in the last 24 months for a total of $18,399,635.85 bought.

Which Accelerate Diagnostics insiders have been selling company stock?

The following insiders have sold Accelerate Diagnostics stock in the last 24 months: Jack Phillips ($355,855.90), Romney Humphries ($80,000.00), Ron Price ($42,466.32), and Steven Reichling ($741,128.78).

How much insider selling is happening at Accelerate Diagnostics?

Insiders have sold a total of 134,367 Accelerate Diagnostics shares in the last 24 months for a total of $1,219,451.00 sold.

This page was last updated on 1/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.